Could a probiotic help manage type 1 diabetes? new study explores safety
NCT ID NCT03961347
First seen Mar 10, 2026 · Last updated May 24, 2026 · Updated 9 times
Summary
This study tested whether a probiotic called Lactobacillus johnsonii N6.2 is safe and tolerable for adults with type 1 diabetes. Forty-six participants took either the probiotic or a placebo daily for 24 weeks, and researchers monitored their blood counts, metabolic panels, and any side effects. The goal was to see if the probiotic could help preserve insulin-producing cells by improving gut health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UF Clinical Research Center
Gainesville, Florida, 32610, United States
Conditions
Explore the condition pages connected to this study.